References
- Merskey H , BogdukN. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms (2nd Edition). Merskey H, Bogduk N (Eds). International Association for the Study of Pain Press, WA, USA (1994).
- Jensen TS , BaronR, HaanpaaM et al. A new definition of neuropathic pain. Pain 152 , 2204–2205 (2011).
- Attal N , BouhassiraD. Can pain be more or less neuropathic? Pain110 , 510–511 (2004).
- Bennett MI , SmithBH, TorranceN, LeeAJ. Can pain be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain122 , 289–294 (2006).
- Marinker M . The medium and the message. Patient Educ. Couns.41 , 117–125 (2000).
- Smith BH , TorranceN. Epidemiology of chronic pain. In: Systematic Reviews in Pain Research: Methodology Refined. McQuay HJ, Kalso E, Moore RA (Eds). International Association for the Study of Pain Press, WA, USA, 247–273 (2008).
- Bowsher D , RiggeM, SoppL. Prevalence of chronic pain in the British population: a telephone survey of 1037 households. Pain Clin.4 , 223–230 (1991).
- Bennett GJ . Neuropathic pain: an overview. In: Molecular Biology of Pain. Borsook D (Ed.). International Association for the Study of Pain Press, WA, USA, 109–113 (1997).
- Smith BH , TorranceN. Epidemiology of neuropathic pain: a review. Pain Manag.1 , 87–96 (2011).
- Smith BH , TorranceN, BennettM, LeeAJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin. J. Pain23 , 143–149 (2007).
- Doth AH , HanssonPT, JensenMP, TaylorRS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain149 , 338–344 (2010).
- Attal N , CruccuG, BaronR et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 17 , 1113–e88 (2010).
- Finnerup NB , SindrupSH, JensenTS. The evidence for pharmacological treatment of neuropathic pain. Pain150 , 573–581 (2010).
- Haanpää M , Backonja M-M, Bennett M et al. Assessment of neuropathic pain in primary care. Am. J. Med.122 , S13–S31 (2009).
- Moulin DE , ClarkAJ, GilronI et al. Pharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain Society. Pain Res. Manag. 12 , 13–21 (2007).
- Hall GC , CarrollD, ParryD, McQuayHJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain122 , 156–162 (2006).
- Torrance N , SmithBH, WatsonMC, BennettMI. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam. Prac.24 , 481–485 (2007).
- Dworkin RH , PanaritesCJ, ArmstrongEP, MaloneDC, PhamSV. Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations? Pain153 , 869–875 (2012).
- Torrance N , FergusonJ, AfolabiE et al. Neuropathic pain in the community: more under-treated than refractory? Pain 154 , 690–699 (2013).
- Bennett MI , AttalN, BackonjaMM et al. Using screening tools to identify neuropathic pain. Pain 127 , 199–203 (2007).
- Smith BH , HigginsC, BaldacchinoA, KiddB, BannisterJ. Gabapentin as a drug of abuse. Br. J. Gen. Prac.62 , 406–407 (2012).
- Rowbotham MC , GilronI, GlazerC et al. Can pragmatic trials help us better understand chronic pain and improve treatment? Pain (2013) (In Press).
▪ Websites
- Cardiff University Pain Community Centre. http://paincommunitycentre.org (Accessed 21December2012)
- NICE clinical guideline 96. Pharmacological management of neuropathic pain in non-specialist settings. http://guidance.nice.org.uk/CG96 (Accessed 21December2012)